Bladder Cancer Clinical Trial

Enhanced Recovery After Surgery (ERAS) for Ambulatory TURBT

Summary

This is a single-center, randomized-controlled trial to investigate the effectiveness of an ERAS protocol compared to usual care in patients with bladder cancer undergoing ambulatory TURBT. The ERAS protocol is comprised of pre, intra and postoperative components designed to optimize each phase of perioperative care.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients with suspected or known bladder cancer
Age >= 18 years
Undergoing initial or repeat TURBT
Ambulatory TURBT with same day discharge home planned

Exclusion Criteria:

Undergoing a planned concomitant procedure
Inability to consent for themselves
Unable to complete telephone-based follow up after discharge home
Undergoing active treatment for muscle-invasive bladder cancer

Study is for people with:

Bladder Cancer

Estimated Enrollment:

100

Study ID:

NCT05905276

Recruitment Status:

Not yet recruiting

Sponsor:

Johns Hopkins University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Johns Hopkins Hospital
Baltimore Maryland, 21287, United States More Info
Michael E Rezaee, MD, MPH
Contact
410-955-4494
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

100

Study ID:

NCT05905276

Recruitment Status:

Not yet recruiting

Sponsor:


Johns Hopkins University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.